Published • loading... • Updated
South Africa Grapples With The Promise And Price Of Injectable Lenacapavir To Prevent HIV
Summary by Health Policy Watch
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
South Africa Grapples With The Promise And Price Of Injectable Lenacapavir To Prevent HIV
The antiretroviral medicine lenacapavir, delivered via injection every six months, is almost completely effective in preventing HIV. But it is expensive at present, and millions will need to be initiated on it every year to make a dent on HIV transmission in South Africa. CAPE TOWN – South Africa has the biggest population of people […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
